Missouri Recalls Infused Marijuana Pre-Rolls After Aspergillus Test Failure
- Missouri marijuana regulators recalled a batch of Juicy – Juicy J’s – Infused Pre Rolls (Cherry Limeade flavor) after detecting the mold Aspergillus, which can pose health risks especially to immunocompromised individuals.
- The recalled product, produced by CCMRB Processing, LLC, failed routine state testing initiated in July 2025 to ensure product safety and compliance with Missouri standards.
- Consumers are advised to stop using the recalled pre-rolls, discard or return them to dispensaries, with returns not affecting medical marijuana purchase limits; no adverse reactions have been reported so far.
- Missouri's Division of Cannabis Regulation has authority to issue public recalls to protect consumer health, and individuals experiencing adverse effects should seek medical care and report incidents to the agency.
Missouri marijuana regulators have issued a recall for a batch of infused pre-rolls after testing detected Aspergillus, a type of mold that can pose health risks in higher amounts or for people with compromised immune systems.
The Missouri Division of Cannabis Regulation (DCR), in partnership with CCMRB Processing, LLC, announced the recall September 16 for Juicy – Juicy J’s – Infused Pre Rolls – 2.5g – 5ct. – CHERRY LIMEADE.
The recalled product is identified by product number M00002615049 and source tag 1A40C0300005E25000004098. It was produced by CCMRB Processing, LLC, license number MAN000103.
According to DCR, the product was tested through the state’s routine sampling initiative, which was launched in July 2025 to monitor product safety, label accuracy and compliance with Missouri testing standards. The recalled batch failed testing for Aspergillus.
Aspergillus is a common mold that can generally be tolerated in small amounts by healthy individuals but may cause adverse health effects when exposure is higher or among people with compromised immune systems.
No adverse reactions related to the recalled product have been reported to DCR.
Regulators are advising patients and adult-use consumers who purchased the product to stop using it. Unused products should either be discarded or returned to the dispensary where they were purchased. Returned products will not count toward a medical marijuana patient’s purchase limit.
Missouri regulations allow DCR to issue a public recall notice when a marijuana product presents a potential threat to health and safety.
Anyone who believes they experienced an adverse reaction is advised to seek medical attention and report the incident to DCR through the agency’s complaint system.